1 Min Read
Nov 7 (Reuters) - Chemocentryx Inc -
* Chemocentryx reports third quarter 2016 financial results and provides corporate update
* Q3 loss per share $ 0.15
* Q3 revenue $4.1 million Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.